Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Immunity & Ageing

Fig. 1

From: TBX21, the Master regulator of the type 1 immune response, overexpresses in the leukocytes of peripheral blood in patients with late-onset Alzheimer’s disease

Fig. 1

Evaluation of TBX21 mRNA expression in the blood cells of LOAD patients. Relative TBX21 mRNA expression is increased in WBCs from LOAD patients compared to those from control individuals. The total number of participants in the patient and control groups was 394. Data are normalized against GAPDH internal control. Bars represent mean values ± SDs. We used an unpaired t test to compare the different groups (****P < 0.0001)

Back to article page